Literature DB >> 313078

Hemophilus influenzae septicemia and polyarthritis in multiple myeloma.

H I Saba, R C Hartmann, J C Herion.   

Abstract

Hemophilus influenzae sepsis, rare in adults, is reported for the first time in association with multiple myeloma. The patient developed fulminant septicemia involving multiple organs and disabling pyarthrosis due to nonencapsulated H influenzae, usually considered to be nonpathogenic. Early diagnosis and appropriate antibiotic therapy cured the infection and prevented permanent joint disease. Also illustrated is the problem of establishing a diagnosis of myclomatosis in patients with septicemia. The English language literature on H influenzae sepsis and polyarthritis in association with myeloma has been reviewed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 313078     DOI: 10.1097/00007611-197906000-00032

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Polyarticular Haemophilus Influenza Septic Arthritis in an HIV Patient.

Authors:  Taha Faruqi; Adam Green; Daniel P McCall; Matthew Caid; Logan C Smith
Journal:  Cureus       Date:  2021-12-04

2.  Polyarticular Septic Arthritis Due to Non-Typeable Haemophilus influenzae With Concomitant New-Onset Acute Gouty Arthritis.

Authors:  Brian Sanders; Mohammed Abdulfatah; Mossab Aljuaid; Ibrahim Tawhari
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

3.  Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China.

Authors:  Yufeng Shang; Weida Wang; Yuxing Liang; Natasha Mupeta Kaweme; Qian Wang; Minghui Liu; Xiaoqin Chen; Zhongjun Xia; Fuling Zhou
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 4.  Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma.

Authors:  Sarah M Tete; Marc Bijl; Surinder S Sahota; Nicolaas A Bos
Journal:  Front Immunol       Date:  2014-06-03       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.